Endurant Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-64,956	Closed	-$444K	–	38
2023 Q1	$444K	Buy	+64,956	New	+$444K	0.23%	43
2016 Q4	–	Sell	-8,400	Closed	-$225K	–	78
2016 Q3	$225K	Buy	+8,400	New	+$225K	0.08%	93